Bio-Techne Corporation
TECH
$60.24
$1.773.02%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 297.03M | 289.46M | 306.10M | 303.43M | 272.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 297.03M | 289.46M | 306.10M | 303.43M | 272.60M |
| Cost of Revenue | 100.27M | 101.36M | 104.39M | 98.00M | 94.65M |
| Gross Profit | 196.76M | 188.10M | 201.71M | 205.43M | 177.94M |
| SG&A Expenses | 118.99M | 111.71M | 109.02M | 107.65M | 105.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 244.27M | 236.94M | 237.40M | 231.41M | 223.51M |
| Operating Income | 52.76M | 52.52M | 68.70M | 72.02M | 49.09M |
| Income Before Tax | 42.88M | 40.17M | 41.66M | 61.08M | 33.39M |
| Income Tax Expenses | 7.99M | 6.57M | 1.07M | 12.03M | 5.92M |
| Earnings from Continuing Operations | 34.89M | 33.60M | 40.59M | 49.06M | 27.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.89M | 33.60M | 40.59M | 49.06M | 27.47M |
| EBIT | 52.76M | 52.52M | 68.70M | 72.02M | 49.09M |
| EBITDA | 79.84M | 80.66M | 96.76M | 99.33M | 76.89M |
| EPS Basic | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 |
| Normalized Basic EPS | 0.19 | 0.21 | 0.26 | 0.26 | 0.18 |
| EPS Diluted | 0.22 | 0.21 | 0.26 | 0.31 | 0.17 |
| Normalized Diluted EPS | 0.19 | 0.20 | 0.25 | 0.26 | 0.17 |
| Average Basic Shares Outstanding | 158.43M | 158.53M | 157.87M | 157.31M | 157.53M |
| Average Diluted Shares Outstanding | 160.63M | 161.12M | 160.65M | 160.50M | 160.06M |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 36.50% | 37.76% | 31.11% | 25.64% | 45.73% |
